View Associated Notes
Category 3 - THERAPEUTIC PROCEDURES
14202 - Additional Information
Item Start Date:
01-Jul-2011
Description Updated:
01-Jul-2011
Schedule Fee Updated:
01-Nov-2023
Group
T1 - Miscellaneous Therapeutic Procedures
Subgroup
13 - Other Therapeutic Procedures
POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953
Fee: $131.95 Benefit: 75% = $99.00 85% = $112.20
(See para TN.1.16 of explanatory notes to this Category)
Associated Notes
Category 3 - THERAPEUTIC PROCEDURES
TN.1.16
Facial Injections of Poly-L-Lactic Acid - (Items 14201 and 14202)
Poly-L-lactic acid is listed within the standard arrangements on the Pharmaceutical Benefits Scheme (PBS) as an Authority Required listing for initial and maintenance treatments, for facial administration only, of severe facial lipoatrophy caused by therapy for HIV infection.
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change